Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$12.19 - $22.43 $36,374 - $66,931
-2,984 Reduced 14.09%
18,201 $392,000
Q3 2023

Nov 06, 2023

BUY
$13.28 - $20.3 $281,336 - $430,055
21,185 New
21,185 $357,000
Q1 2023

May 04, 2023

SELL
$19.47 - $28.49 $15,050 - $22,022
-773 Reduced 3.57%
20,863 $474,000
Q4 2022

Feb 06, 2023

SELL
$18.08 - $30.0 $4,140 - $6,870
-229 Reduced 1.05%
21,636 $509,000
Q2 2022

Aug 05, 2022

BUY
$16.0 - $45.99 $349,840 - $1.01 Million
21,865 New
21,865 $480,000
Q4 2021

Feb 03, 2022

SELL
$39.06 - $67.58 $128,194 - $221,797
-3,282 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$50.07 - $76.78 $1.38 Million - $2.11 Million
-27,496 Reduced 89.34%
3,282 $241,000
Q1 2021

May 05, 2021

SELL
$58.92 - $97.33 $1.21 Million - $1.99 Million
-20,453 Reduced 39.92%
30,778 $2.11 Million
Q4 2020

Feb 04, 2021

BUY
$43.6 - $73.05 $172,002 - $288,182
3,945 Added 8.34%
51,231 $3.44 Million
Q3 2020

Nov 02, 2020

BUY
$38.47 - $52.03 $784,941 - $1.06 Million
20,404 Added 75.9%
47,286 $2.43 Million
Q2 2020

Aug 05, 2020

BUY
$27.28 - $43.01 $165,207 - $260,468
6,056 Added 29.08%
26,882 $1.01 Million
Q1 2020

May 04, 2020

BUY
$23.08 - $35.53 $480,664 - $739,947
20,826 New
20,826 $621,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $750M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.